Skip to content
  1. 2023
  2. 2022
  3. 2021
  4. 2020
  5. 2019
  6. 2018

November 20, 2020

ExCEEd Orphan continues cooperation with Novartis Gene Therapies for Zolgensma®

ExCEEd Orphan will continue next year in cooperation with Novartis Gene Therapies (previously …

November 4, 2020

ExCEEd Orphan announces new members of the team

ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in …

October 5, 2020

ExCEEd Orphan starts cooperation with Hansa Biopharma

The ExCEEd Orphan announces its cooperation with Hansa Biopharma in commercialization of IDEFIRIX …

October 1, 2020

ExCEEd Orphan announces its cooperation with Pharming

The ExCEEd Orphan announces its cooperation with Pharming in commercialization of RUCONEST® (conestat …

September 9, 2020

ExCEEd Orphan signed cooperation with Ernst & Young

The ExCEEd Orphan announces its cooperation with Ernst & Young on designing compliance …

September 1, 2020

ExCEEd Orphan extends cooperation with Kyowa Kirin

The ExCEEd Orphan announces extension of its consulting cooperation with Kyowa Kirin in …

August 19, 2020

ExCEEd Orphan announces its cooperation with Neox company

The ExCEEd Orphan announces its cooperation with Neox, Czech based company. Neox will …

August 1, 2020

ExCEEd Orphan announces new organizational structure and related appointments

ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in …

July 1, 2020

ExCEEd Orphan announces opening of the first foreign affiliate in Croatia

The ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions …

June 1, 2020

ExCEEd Orphan cooperation with Kyowa Kirin extended for Romania

The ExCEEd Orphan announces its consulting cooperation extension with Kyowa Kirin (https://www.kyowakirin.com/) in …

June 1, 2020

ExCEEd Orphan initiates cooperation with Novartis Hungary for Zolgensma®

The ExCEEd Orphan announces initiation of its consulting cooperation with Novar-tis Hungary for …

June 1, 2020

ExCEEd Orphan continues cooperation with AveXis for Zolgensma®

AveXis continues in cooperation with ExCEEd Orphan in North Macedonia for Zolgensma®, the …

May 19, 2020

AveXis receives EC approval for Zolgensma®

AveXis receives EC approval and activates “Day One” access program for Zolgensma®, the …

May 15, 2020

First SMA Patient in Czechia was treated with gene therapy in Faculty Hospital in Motol

Little Max is the first patient with spinal muscular atrophy who received systemic …

May 6, 2020

Gene Therapy reimbursed for SMA patients in Czechia

Czech Health Insurance companies recently approved reimbursement of breakthrough gene therapy treatment for …

April 8, 2020

Eurodis and Covid 19 Pandemic

April 8, 2020 EURORDIS open letter to policy makers: Recommendations to protect people …

April 1, 2020

Kyowa Kirin cooperation extended

April 1, 2020 The company ExCEEd Orphan announces its consulting cooperation expansion with …

March 27, 2020

AveXis receives positive CHMP opinion for Zolgensma®

AveXis receives positive CHMP opinion for Zolgensma®, the only gene therapy for spinal …

March 20, 2020

Novartis receives approval from Japanese Ministry of Health, Labour and Welfare for Zolgensma®

Novartis receives approval from Japanese Ministry of Health, Labour and Welfare for Zolgensma® …

February 28, 2020

Rare Disease Day support

ExCEEd Orphan is honoured and engaged to support Rare Disease Day campaign and …